Replacing Bacitracin With Vancomycin in Adams Triple Antibiotic Solution for Irrigation in Breast Implant Reconstruction: A Retrospective Review of 277 Reconstructions.

Eplasty Pub Date : 2025-09-25 eCollection Date: 2025-01-01
Quinton L Carr, Colton H Connor, Ryan Cantrell, Shriya Dodwani, Alexander L Mostovych, Marcus Bennett, Samuel L Corey, Dexter W Weeks, Anthony Azzolini, Carter Prewitt, Bradon J Wilhelmi
{"title":"Replacing Bacitracin With Vancomycin in Adams Triple Antibiotic Solution for Irrigation in Breast Implant Reconstruction: A Retrospective Review of 277 Reconstructions.","authors":"Quinton L Carr, Colton H Connor, Ryan Cantrell, Shriya Dodwani, Alexander L Mostovych, Marcus Bennett, Samuel L Corey, Dexter W Weeks, Anthony Azzolini, Carter Prewitt, Bradon J Wilhelmi","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Breast reconstruction following mastectomy commonly involves tissue expanders to create a suitable pocket for implantation. The use of triple antibiotic irrigation during tissue expander placement aims to reduce implant-related infections. Implant infections can lead to severe complications, often necessitating revision surgeries that may delay treatment of other conditions, such as cancer. For years, the most common solution used in breast pocket irrigation was the Adams solution, which comprises 80 mg gentamicin, 1 g cefazolin, and 50 000 U bacitracin in 500 mL of normal saline. However, the discontinuation of bacitracin has prompted the search for alternative formulations. Vancomycin, like bacitracin, has been shown to provide gram-positive coverage-only better. This study aims to evaluate the utility of a triple antibiotic solution (TAS) containing gentamicin, cefazolin, and vancomycin as a replacement for bacitracin in reducing infection rates following tissue expander placement.</p><p><strong>Methods: </strong>A single-center retrospective chart review was conducted, including 152 patients who underwent a total of 277 breast reconstructions with a TAS comprising 80 mg gentamicin, 1 g cefazolin, and 1 g vancomycin from March 2020 to June 2024. Demographic and clinical data, perioperative characteristics, and postoperative outcomes-including infection rates and culture results-were analyzed.</p><p><strong>Results: </strong>Infections occurred in 6 of 277 reconstructions (2.17% of implants). Methicillin-resistant <i>Staphylococcus aureus</i> was a significant pathogen in infections (50.00%). None of the systemic side effects of vancomycin, including nephrotoxicity, ototoxicity, or vancomycin flushing syndrome, were encountered. Furthermore, no evidence of drug-resistant bacteria was reported in any of the cases.</p><p><strong>Conclusions: </strong>This study highlights the potential utility of vancomycin as an acceptable alternative to bacitracin in triple antibiotic irrigation solution following tissue expander placement post-mastectomy. Additional research could help to further establish vancomycin's efficacy and safety. If validated, this approach could be a temporary alternative to the Adams solution until a better long-term strategy is identified.</p>","PeriodicalId":93993,"journal":{"name":"Eplasty","volume":"25 ","pages":"e35"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12975522/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eplasty","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Breast reconstruction following mastectomy commonly involves tissue expanders to create a suitable pocket for implantation. The use of triple antibiotic irrigation during tissue expander placement aims to reduce implant-related infections. Implant infections can lead to severe complications, often necessitating revision surgeries that may delay treatment of other conditions, such as cancer. For years, the most common solution used in breast pocket irrigation was the Adams solution, which comprises 80 mg gentamicin, 1 g cefazolin, and 50 000 U bacitracin in 500 mL of normal saline. However, the discontinuation of bacitracin has prompted the search for alternative formulations. Vancomycin, like bacitracin, has been shown to provide gram-positive coverage-only better. This study aims to evaluate the utility of a triple antibiotic solution (TAS) containing gentamicin, cefazolin, and vancomycin as a replacement for bacitracin in reducing infection rates following tissue expander placement.

Methods: A single-center retrospective chart review was conducted, including 152 patients who underwent a total of 277 breast reconstructions with a TAS comprising 80 mg gentamicin, 1 g cefazolin, and 1 g vancomycin from March 2020 to June 2024. Demographic and clinical data, perioperative characteristics, and postoperative outcomes-including infection rates and culture results-were analyzed.

Results: Infections occurred in 6 of 277 reconstructions (2.17% of implants). Methicillin-resistant Staphylococcus aureus was a significant pathogen in infections (50.00%). None of the systemic side effects of vancomycin, including nephrotoxicity, ototoxicity, or vancomycin flushing syndrome, were encountered. Furthermore, no evidence of drug-resistant bacteria was reported in any of the cases.

Conclusions: This study highlights the potential utility of vancomycin as an acceptable alternative to bacitracin in triple antibiotic irrigation solution following tissue expander placement post-mastectomy. Additional research could help to further establish vancomycin's efficacy and safety. If validated, this approach could be a temporary alternative to the Adams solution until a better long-term strategy is identified.

用万古霉素代替杆菌肽在Adams三抗生素溶液中冲洗乳房假体重建术:277例回顾性分析。
目的:乳房切除术后的乳房重建通常需要组织扩张器来创造一个合适的植入袋。在组织扩张器放置期间使用三重抗生素冲洗旨在减少植入物相关感染。种植体感染会导致严重的并发症,通常需要进行修复手术,这可能会延迟其他疾病(如癌症)的治疗。多年来,乳房口袋冲洗中最常用的溶液是亚当斯溶液,其中包括80毫克庆大霉素,1克头孢唑林和5万U杆菌肽在500毫升生理盐水中。然而,杆菌肽的停用促使人们寻找替代配方。万古霉素和杆菌肽一样,已被证明能提供革兰氏阳性覆盖率——而且更好。本研究旨在评估含有庆大霉素、头孢唑林和万古霉素的三重抗生素溶液(TAS)在降低组织扩张器放置后感染率方面的效用。方法:采用单中心回顾性图表分析,纳入152例患者,共277例乳房重建术,TAS由80 mg庆大霉素、1 g头孢唑林和1 g万古霉素组成,时间为2020年3月至2024年6月。对人口统计学和临床资料、围手术期特征和术后结果(包括感染率和培养结果)进行分析。结果:277个重建体中有6个(2.17%)发生感染。耐甲氧西林金黄色葡萄球菌是感染的主要病原菌(50.00%)。没有发现万古霉素的全身副作用,包括肾毒性、耳毒性或万古霉素潮红综合征。此外,在任何病例中都没有报告耐药细菌的证据。结论:本研究强调了万古霉素作为乳房切除术后组织扩张器放置后三联抗生素冲洗液中杆菌肽的可接受替代品的潜在用途。进一步的研究有助于进一步确定万古霉素的有效性和安全性。如果得到验证,在确定更好的长期战略之前,这种方法可以作为Adams解决方案的临时替代方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书